A Study to Evaluate the Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab in Combination With Other Cancer Immunotherapies for the Treatment of Advanced Cancer
A Phase 1b/2 Open-Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination With Other Cancer Immunotherapies in Patients With Advanced Malignancies
Category & Conditions: Cancer
Medicine: Bavencio (avelumab)
ClinicalTrials.gov Identifier (NCT): NCT02554812
Protocol ID: B9991004
PrintDownloadOpen Plain Language Summary Result: Click here